Moreover, creatinine-based eGFR is less accurate in patients with lower GFR or chronic kidney disease, and thus utilizing both cystatin c, and creatinine has been strongly suggested to accurately determine renal function in these patients [58, 60]. This evidence concerns the gene CST3 and chronic kidney disease.